Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. Gains 12%; BSE HEALTHCARE Index Down 0.1%
Wed, 14 Aug 9:27

MARKSANS PHARMA. Gains 12%; BSE HEALTHCARE Index Down 0.1%Image source: Eoneren/www.istockphoto.com

MARKSANS PHARMA. share price has zoomed 12% and is presently trading at Rs 205.2.

Meanwhile, the BSE HEALTHCARE index is at 41,000.5 (down 0.1%).

Among the top gainers in the BSE HEALTHCARE index today are AJANTA PHARMA (up 6.4%) and ALEMBIC PHARMA (up 1.7%).

Divis Laboratories (down 2.2%) and ASTRAZENECA PHARMA (down 1.7%) are among the top losers today.

Over the last one year, MARKSANS PHARMA. has moved up from Rs 113.9 to Rs 205.2, registering a gain of Rs 91.3 (up 80.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 41,000.5, registering a gain of 47.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 129.7%), GSK Pharma (up 99.8%) and SUVEN PHARMACEUTICALS (up 98.5%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 78,980.1 .

The top gainers among the BSE Sensex today are Tech Mahindra (up 1.0%) and M&M (up 0.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,146.7 . Hindalco and HCl Tech. are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 78,980.1, registering a gain of 13,578.2 points (up 20.8%).

MARKSANS PHARMA. Financial Update...

MARKSANS PHARMA. net profit grew 26.4% YoY to Rs 891 million for the quarter ended June 2024, compared to a profit of Rs 704 million a year ago. Net sales rose 18.1% to Rs 5,906 million during the period as against Rs 5,000 million in April-June 2023.

For the year ended March 2023, MARKSANS PHARMA. reported 42.0% increase in net profit to Rs 2,653 million compared to net profit of Rs 1,868 million during FY22. Revenue of the company grew 24.2% to Rs 18,521 million during FY23.

The current Price to earnings ratio of MARKSANS PHARMA., based on rolling 12 month earnings, stands at 27.9.


Equitymaster requests your view! Post a comment on "MARKSANS PHARMA. Gains 12%; BSE HEALTHCARE Index Down 0.1%". Click here!